Voyager Biomedical
Houston
About Voyager Biomedical
Voyager Biomedical, Inc. is committed to improving the lives of dialysis patients through the development of a novel vascular access device known as the ARK. The ARK has been designed to facilitate targeted needle placement and strengthen the vein by serving as a supportive exoskeleton. In addition, the ARK will increase patient comfort, and reduce stress and increase efficiency for caregivers, while benefiting the payer system by decreasing the surgeries necessary to enable long-term vascular access.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $5.8M
- Last round: Series Unknown (Apr 2025)
- Website: voyagerbiomedical.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/voyager-biomedical-68515 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.